ArticleParasites & vectors2017
Efficacy of the vegetative cells of Lysinibacillus sphaericus for biological control of insecticide-resistant Aedes aegypti.
Article in Parasites & vectors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 26 citations in OpenAlex.
- Screening of environmental fungi from Crete reveals candidates for biological control of mosquitoes.Journal of medical entomology · 2026Article
- Entomopathogen-based biopesticides: insights into unraveling their potential in insect pest management.Frontiers in microbiology · 2023Review
- Triple-valve endocarditis due toIDCases · 2023Article
- Mosquito-larvicidal Binary (BinA/B) proteins for mosquito control programs -advancements, challenges, and possibilities.Current research in insect science · 2022Review
- First record of entomopathogenic nematodes from Yucatán State, México and their infectivity capacity againstPeerJ · 2021Article
- Assessment of the Synergic Effect betweenInsects · 2020Article
- Synergistic effect of Lysinibacillus sphaericus and glyphosate on temephos-resistant larvae of Aedes aegypti.Parasites & vectors · 2020Article
- Contribution of Lysinibacillus sphaericus hemolysin and chitin-binding protein in entomopathogenic activity against insecticide resistant Aedes aegypti.World journal of microbiology & biotechnology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe control of Aedes aegypti is usually based on chemical insecticides, but the overuse of these compounds has led to increased resistance. The binary toxin produced by Lysinibacillus sphaericus in the final stages of sporulation is used for mosquito control due to its specificity against the culicid larvae; however, it has been proved that Ae. aegypti is refractory for this toxin. Currently, there is no evidence of the use of L. sphaericus vegetative cells for mosquito biocontrol. Therefore, in this study, the vegetative cells of three L. sphaericus strains were assessed against a field-collected Ae. aegypti, resistant to temephos, and the reference Rockefeller strain.
resultsVegetative cells of L. sphaericus 2362, III(3)7 and OT4b.25 produced between 90% and 100% of larvae mortality in the reference Rockefeller strain. Effective concentrations of each L. sphaericus strain for the four larval stages ranged from 1.4 to 2 × 10
conclusionsThe vegetative cells of L. sphaericus are effective against Ae. aegypti larvae, meaning that it could be used in the biological control of these mosquito species. Since the L. sphaericus consortium was effective against temephos-resistant Ae. aegypti, vegetative cells could be an alternative to overcome insecticide-resistant populations. Further studies, should be conducted to reveal the mode of action and the toxic principle of L. sphaericus vegetative cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.